The medium-sized biopharma is showing off new results from dordaviprone and Zepzelca, both of which were acquired through ...

A groundbreaking technology designed to attack lung tumors and shorten recovery times for patients is now available at St.

For the third year in a row, a group of runners will lace up their shoes and take to the streets of Dublin this weekend for the VHI Women’s Mini Marathon. They are doing so in memory of Eve McMahon, a ...

T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

Amplia Therapeutics is making strides with its candidate that works on the anti-fibrotic path to tackling pancreatic cancer.

The daughter of a Bridgeport Navy veteran who died of cancer is hosting a swim-a-thon fundraiser in his honor. The proceeds ...

Shares of Merus NV (NASDAQ:MRUS) were trading at $54.35, up $12.75, or 30%, on interim data as of Feb. 27 from the phase II trial of bispecific antibody petosemtamab in combination with Merck & Co.

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...

Retroviral vectors that are both non-replicating and non-integrating represent a novel and attractive tool that has potential advantages for gene delivery therapy, immunotherapy, and vaccinology.

Ascension St. Vincent's St. Johns is 1 of 8 hospitals offering a new non-surgical weight-loss procedure. Patients and doctor ...

CDMO Andelyn Biosciences says that it has manufactured a viral vector with its AAV Curator ® Platform for the Nationwide Children’s Hospital’s Cellular Therapy and Cancer Immunology Program.

Emeritus Professor Allan Spigelman is at the centre of an internal review of medical records for more than 1600 patients at St Vincent’s Hospital Sydney’s cancer genetic service between April ...